James D. Clark - 28 Jan 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Issuer symbol
CVS
Transactions as of
28 Jan 2022
Net transactions value
-$40,838
Form type
4
Filing time
01 Feb 2022, 15:43:23 UTC
Previous filing
14 Oct 2022
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $619,593 +6,059 +35% $102.26 23,556 28 Jan 2022 Direct
transaction CVS Common Stock Sale $660,431 -6,059 -26% $109.00 17,497 28 Jan 2022 Direct F1
holding CVS Common Stock (restricted) 16,921 28 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -6,059 -100% $0.000000* 0 28 Jan 2022 Common Stock 6,059 $102.26 Direct F2
holding CVS Stock Option 24,240 28 Jan 2022 Common Stock 24,240 $54.19 Direct F3
holding CVS Stock Option 7,513 28 Jan 2022 Common Stock 7,513 $62.21 Direct F4
holding CVS Stock Option 9,050 28 Jan 2022 Common Stock 9,050 $78.05 Direct F5
holding CVS Stock Option 7,044 28 Jan 2022 Common Stock 7,044 $104.82 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Options became exercisable in four equal annual installments beginning on 4/1/2016.
F3 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F4 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F5 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F6 Options became exercisable in four equal annual installments beginning on 4/1/2017.